Chronic and Health Equity Program
Breast Cancer Disparities Impact Black Women
Black women face a higher risk of dying from breast cancer than women of other racial and ethnic groups, highlighting the urgent need for awareness, early detection, and equitable access to quality care.


You can reduce your risk of breast cancer, and help ensure a healthier future for yourself. Staying active, keeping a healthy weight, and eating right all play a role.
This year alone, more than 2,000 Mississippi women could be diagnosed with breast cancer.
Early detection of breast cancer saves lives — but Mississippi has one of the lowest breast cancer screening rates in the nation for older women.

This Month: Celebrating More than 30 Years of NBCC Advocacy
In 1991, a group of women decided breast cancer needed a powerful advocacy arm with a single mission: to eradicate the disease. Since then, NBCC has been at the forefront of the breast cancer movement. This Women’s History Month, explore NBCC’s rich history and celebrate the advocates who have been working to end breast cancer since the beginning.

Did you know? This year, an estimated 42,670 women and 530 men in the US will die of breast cancer. The latest breast cancer facts and figures demonstrate the ongoing, urgent need to end this disease—learn them, download them (PDF), and spread the word.

The FDA recently announced that one pivotal trial will become the default for drug approval. NBCC believes “if FDA moves to a one-trial default, it must ensure confirmatory evidence does not substitute for strong trial design and clinically meaningful results.”

Over decades of advocacy, we’ve learned one thing: progress does not happen on its own. It happens because people organize, speak clearly, and refuse to back down. Join us—become a member of NBCC and add your voice to a movement that saves lives.

A new stopbreastcancer.org is coming this fall, and NBCC wants to hear from you: How could our website better meet your needs? Please complete a brief survey to share your feedback and help inform our design and content strategy.

What do faster drug approvals mean for patients, evidence standards, and health care costs? On March 23 at 12 PM EST, Dr. Huseyin Naci will discuss his research on survival gains and Medicare spending associated with accelerated approvals. Register to join; NBCC membership required.
